NASDAQ:INMB | Profit Breakdown | Inmune Bio, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$1.48M-$1.27M
2026-03-31-$5.81M-$5.41M
2025-12-31$0.00-$5.47M-$5.26M
2025-09-30-$7.43M-$6.47M
2025-06-30-$24.57M-$24.46M
2025-03-31$50,000.00-$9.91M-$9.74M
2024-12-31$0.00-$9.47M-$9.22M
2024-09-30-$12.29M-$12.09M
2024-06-30-$9.87M-$9.75M
2024-03-31$14,000.00-$11.02M-$11.03M
2023-12-31$28,000.00-$8.38M-$8.41M
2023-09-30$43,000.00-$8.53M-$8.56M
2023-06-30$46,000.00-$6.41M-$6.5M
2023-03-31$38,000.00-$6.42M-$6.54M
2022-12-31$97,000.00-$5.64M-$5.83M
2022-09-30$98,000.00-$7.44M-$7.73M
2022-06-30$16,000.00-$6.39M-$6.84M
2022-03-31$163,000.00-$6.48M-$6.9M
2021-12-31$163,000.00-$9.03M-$9.67M
2021-09-30$14,000.00-$9.02M-$9.46M
2021-06-30-$6.55M-$6.66M
2021-03-31$4,000.00-$4.55M-$4.56M
2020-12-31-$3.21M-$3.2M
2020-09-30-$4.82M-$4.72M
2020-06-30-$2.11M-$2.11M
2020-03-31-$2.09M-$2.07M
2019-12-31-$2.33M-$2.32M
2019-09-30-$3.08M-$3.07M
2019-06-30$0.00-$428,423.00-$392,083.00
2019-03-31$0.00-$1.91M-$1.9M
2018-12-31-$1.88M-$1.88M
2018-09-30-$1.54M-$1.54M
2018-06-30$0.00-$6.17M-$6.17M
2018-03-31$0.00-$2.85M-$2.85M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$50,000.00-$47.38M$45.93M-$45.93M
2024-12-31$14,000.00-$42.64M$42.08M-$42.08M
2023-12-31$155,000.00-$29.74M$30.01M-$30.01M
2022-12-31$374,000.00-$25.95M-$27.3M
2021-12-31$181,000.00-$29.15M-$30.34M
2020-12-31$11,000.00-$12.23M-$12.1M
2019-12-31-$7.76M-$7.68M
2018-12-31$0.00-$12.44M-$12.44M
2017-12-31$0.00-$981,480.00-$831,486.00